NEOS - Neos Therapeutics EPS misses by $0.05 misses on revenue November, 09 2020 07:05 AM Neos Therapeutics Inc. Neos Therapeutics (NEOS): Q3 GAAP EPS of -$0.10 misses by $0.05.Revenue of $12.54M (-28.5% Y/Y) misses by $2.93M.Press Release For further details see: Neos Therapeutics EPS misses by $0.05, misses on revenue